BIOmarker driven intensification of cardiovascular RISK factor management in patients with high risk for recurrent cardiovascular EVENTs

Conditions

Acute Myocardial Infarction

Brief summary

Time to first event of a composite of cardiovascular outcomes encompassing - Cardiovascular death - Non-fatal myocardial infarction -Non-fatal stroke - Hospitalisation for urgent coronary revascularisation - Hospitalisation for heart failure

Detailed description

Time to first event for cardiovascular death, Time to all-cause mortality, Time to first event for non-fatal myocardial infarction, Time to first event for non-fatal stroke, Time to first event for hospitalisation for urgent coronary revascularisation, Time to first event for hospitalisation for heart failure, Time to first event of a composite of cardiovascular outcomes encompassing -Cardiovascular death -Non-fatal myocardial infarction -Non-fatal stroke, Time to first event of a composite of cardiovascular outcomes encompassing -Cardiovascular death -Hospitalisation for heart failure, Time to first event for any urgent revascularisation procedure of a -Coronary artery -Carotid artery -Peripheral artery, Time to first event for major adverse limb events

Related papers

No related papers found yet.

Interventions

DRUGCOLCHICINE

DRUGEMPAGLIFLOZIN

DRUGVazkepa 998 mg soft capsules

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Time to first event of a composite of cardiovascular outcomes encompassing - Cardiovascular death - Non-fatal myocardial infarction -Non-fatal stroke - Hospitalisation for urgent coronary revascularisation - Hospitalisation for heart failure	—

Secondary

Measure	Time frame
Time to first event for cardiovascular death, Time to all-cause mortality, Time to first event for non-fatal myocardial infarction, Time to first event for non-fatal stroke, Time to first event for hospitalisation for urgent coronary revascularisation, Time to first event for hospitalisation for heart failure, Time to first event of a composite of cardiovascular outcomes encompassing -Cardiovascular death -Non-fatal myocardial infarction -Non-fatal stroke, Time to first event of a composite of cardiovascular outcomes encompassing -Cardiovascular death -Hospitalisation for heart failure, Time to first event for any urgent revascularisation procedure of a -Coronary artery -Carotid artery -Peripheral artery, Time to first event for major adverse limb events	—

Measure

Time frame

Time to first event for cardiovascular death, Time to all-cause mortality, Time to first event for non-fatal myocardial infarction, Time to first event for non-fatal stroke, Time to first event for hospitalisation for urgent coronary revascularisation, Time to first event for hospitalisation for heart failure, Time to first event of a composite of cardiovascular outcomes encompassing -Cardiovascular death -Non-fatal myocardial infarction -Non-fatal stroke, Time to first event of a composite of cardiovascular outcomes encompassing -Cardiovascular death -Hospitalisation for heart failure, Time to first event for any urgent revascularisation procedure of a -Coronary artery -Carotid artery -Peripheral artery, Time to first event for major adverse limb events

—

Countries

Austria, Germany, Poland

Outcome results

None listed